NM_015158.5:c.-84+50877A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015158.5(KANK1):​c.-84+50877A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 152,080 control chromosomes in the GnomAD database, including 15,692 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 15692 hom., cov: 33)

Consequence

KANK1
NM_015158.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.366

Publications

3 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.575 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015158.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
NM_015158.5
MANE Select
c.-84+50877A>G
intron
N/ANP_055973.2
KANK1
NM_001256876.3
c.-84+14964A>G
intron
N/ANP_001243805.1
KANK1
NM_001256877.3
c.-84+5910A>G
intron
N/ANP_001243806.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KANK1
ENST00000382297.7
TSL:1 MANE Select
c.-84+50877A>G
intron
N/AENSP00000371734.2
KANK1
ENST00000382303.5
TSL:1
c.-84+14964A>G
intron
N/AENSP00000371740.1
KANK1
ENST00000619269.5
TSL:5
c.-84+50877A>G
intron
N/AENSP00000477725.2

Frequencies

GnomAD3 genomes
AF:
0.414
AC:
62885
AN:
151962
Hom.:
15699
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.515
Gnomad AMR
AF:
0.381
Gnomad ASJ
AF:
0.472
Gnomad EAS
AF:
0.235
Gnomad SAS
AF:
0.594
Gnomad FIN
AF:
0.505
Gnomad MID
AF:
0.472
Gnomad NFE
AF:
0.567
Gnomad OTH
AF:
0.442
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.413
AC:
62870
AN:
152080
Hom.:
15692
Cov.:
33
AF XY:
0.413
AC XY:
30676
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.143
AC:
5938
AN:
41516
American (AMR)
AF:
0.381
AC:
5811
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.472
AC:
1638
AN:
3468
East Asian (EAS)
AF:
0.235
AC:
1214
AN:
5172
South Asian (SAS)
AF:
0.594
AC:
2861
AN:
4820
European-Finnish (FIN)
AF:
0.505
AC:
5334
AN:
10560
Middle Eastern (MID)
AF:
0.452
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
0.567
AC:
38552
AN:
67954
Other (OTH)
AF:
0.435
AC:
919
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1616
3232
4849
6465
8081
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.523
Hom.:
11502
Bravo
AF:
0.388
Asia WGS
AF:
0.352
AC:
1225
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.59
DANN
Benign
0.67
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2804311; hg19: chr9-555631; API